s
NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation
22-02-2024, 15:10
MINNEAPOLIS, Feb. 22, 2024 /PRNewswire/ — NeoChord is a privately held, medical technology company and the world-leader in beating heart delivery of artificial chords in the treatment of mitral valve regurgitation. The company appointed Todd Berg as Chief Executive Officer to oversee clinical and commercial programs for transeptal and transapical repair of damaged mitral valve chords […] L'articolo NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation proviene da La Ragione.
CONTINUA A LEGGERE
16
0
0
Guarda anche
La Ragione
Ieri, 21:43
Gakpo e Malen trascinano l’Olanda ai quarti, Romania ko 3-0
La Ragione
Ieri, 20:57
Calcio: Brasile, legge stabilisce 19 novembre il giorno di O’Rei Pelé
La Ragione
Ieri, 20:43
Pogacar vince sul Galibier in solitaria e torna in maglia gialla
La Ragione
Ieri, 19:43